General Requirements
Submit documents in English and save them in PDF Archive (PDF/A) format. Include a cover page with:
- Official Title — Use the exact title entered in the ClinicalTrials.gov study record.
- ClinicalTrials.gov ID (NCT number) — Include the number if one has been assigned.
- Document Date — Use the date of the latest update and, when applicable, approval by the human subjects protection review board. The date on the cover page must match the Document Date field in PRS.
Protocol and Statistical Analysis Plan
For applicable clinical trials with a Primary Completion Date on or after January 18, 2017, submit the current protocol and statistical analysis plan (SAP) with your results. Upload the SAP separately if it is a separate document. Include applicable amendments that apply across all study sites and have received review board approval when required. If either document has changed since the previous partial results submission, include the revised version with the next submission.
- Study protocol — Describes the study’s objectives, design, and methods. It may also include scientific background and statistical considerations.
- Statistical analysis plan (SAP) — Explains how the study data will be analyzed, including the methods used, any adjustments for multiple comparisons, and how the study team checked key assumptions.
Preparing Your Documents
Use the protocol document approved with your Institutional Review Board (IRB) application, if available. If you need to prepare a protocol, use the Protocol Template and draw from your approved IRB application or grant materials. Use the application’s printer version as source material for the protocol. You can adapt the template headings as long as you cover the elements described above and include the required cover-page information.
Before submitting, the responsible party may redact personally identifiable information, trade secrets, or confidential commercial information from the protocol or SAP, except where ClinicalTrials.gov (http://clinicaltrials.gov/) registration or results reporting rules require that information.
Informed Consent Form
The Revised Common Rule requires public posting of an informed consent form for federally conducted or supported clinical trials that are subject to the rule and have enrolled participants.
At Pitt, studies initially approved before January 21, 2019, generally follow the Pre-2018 Rule. For a multisite trial, the posting requirement can apply if a participating institution formally transitions the trial to the revised rule while the posting window is still open.
Who posts the form?
For awardee-led trials, the awardee is responsible for ensuring the form is posted. At Pitt, the principal investigator handles posting.
Which form should I post?
Post one IRB-approved consent form per trial. Use a version that was used to enroll participants and include the approval stamp where applicable.
When should I post it?
Post after recruitment closes and no later than 60 days after any participant’s last protocol-required study visit.
Where should I post it?
If the trial is registered on ClinicalTrials.gov and you have an approved English-language form, Pitt recommends uploading it to the study record. Otherwise, follow the HHS instructions for posting to Regulations.gov.
What if the form contains information that may need to be redacted?
Direct questions about consent form redactions to the federal department or agency funding the trial.
OHRP Informed Consent Posting Instructions